Gene therapy in Europe: the first swallow
Glybera is the first gene therapy drug in Western countries. It has already received approval in 2012, but final approval for its sale is expected by April next year.
01.12.2014Glybera is the first gene therapy drug in Western countries. It has already received approval in 2012, but final approval for its sale is expected by April next year.
01.12.2014On December 6, Konstantin Popadyin, a biologist and researcher at the Institute of Information Transmission Problems of the Russian Academy of Sciences, will speak as part of the Festival of Public Lectures #KNOW. The topic of the lecture is "Young and old genes in the human genome".
01.12.2014The event, organized by the National Association of Business Angels with the support of RVC, brought together more than 150 participants: private investors, representatives of venture funds, large corporations, development institutions and authorities.
01.12.2014The early results of the MPDL3280A clinical trial are so promising that the FDA has awarded it the status of breakthrough therapy, i.e. a drug for the treatment of life-threatening diseases, the higher effectiveness of which compared to traditional means has been proven by convincing clinical data.
01.12.2014The first batch of HealBe GoBe will appear in Moscow in mid-December (at least, that's what the manufacturer promises). The approximate price is about 12 thousand rubles.
28.11.2014On the eve of the lecture on November 30, within the framework of the Festival of Public Lectures #KNOW correspondent "Polit.ru" spoke with the chief researcher of the Institute of General Genetics named afterVavilov by Sergey Kiselyov.
28.11.2014Since the discovery of penicillin, mankind has been constantly conducting a kind of "arms race" with the world of bacteria. And, alas, today in this race we have begun to gradually lag behind the enemy...
28.11.2014Did one of the best tennis players of our time, Rafael Nadal Nadal, make a mistake by choosing stem cell treatment? Will medical technologies help Akinfeev, Yagudin and other athletes?
28.11.2014Researchers at the University of Montreal compared the effectiveness of three methods of treating type 1 diabetes: one- and two-hormone external "pancreas" with feedback and a conventional continuous insulin pump.
28.11.2014The new electronic implant on remote control eliminates bacterial infection by heating the affected tissue, after which it dissolves in the body without a trace.
28.11.2014Even the formation of atherosclerotic plaques on the walls of large arteries, which is not accompanied by symptoms, is associated with impaired cognitive functions.
28.11.2014In one of the brands of electronic cigarettes tested by Japanese scientists, the level of carcinogens was more than 10 times higher than their content in a regular cigarette.
28.11.2014The robotic complex for growing cells in FEFU became the first of its kind in Russia and has only two analogues in the world, which work in leading research centers in the USA and France.
28.11.2014The company Organovo, known for its discoveries in the field of 3D bioprinting, has launched the artificial human liver tissue exVive3D for preclinical testing of new drugs.
27.11.2014The creation of a specialized three-dimensional printer and contact lenses with displays based on organic LEDs was funded by the US Air Force. But such technology has the possibility of a more peaceful use.
27.11.2014The number of registered HIV cases in the Russian Federation may reach 1 million by the end of 2015. At the same time, mortality among HIV-positive patients is increasing, according to the report of the FNMC for the prevention and control of AIDS.
27.11.2014Russian molecular biologist – about the future of gene medicine, why there is no need to be afraid of GMOs, why stem cells are needed and how scientists plan to defeat cancer.
27.11.2014One of the problems with Parkinson's disease may be a violation of the process of removing neurons with defective mitochondria. Instead, there is an accumulation of damaged neurons that are unable to perform their functions.
27.11.2014Genetic differences in the mitochondria of eggs used in the transfer of nuclei to obtain pluripotent stem cells trigger the process of immune rejection, but this is not the reason for rejecting the idea of using this method in the clinic.
27.11.2014Big Pharma is in crisis, it is looking for ways to improve the efficiency of promoting medicines from the laboratory to the market. The Russian "New Pharma" has every chance to work ahead of the curve and release a pool of innovative drugs faster than its Western counterparts.
26.11.2014You can write to the editor at:
vm@vechnayamolodost.ruThe editors of Eternal Youth are preparing a useful and interesting mailing list. You can get it if you leave your mail.